Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial by Elisabeth De Leeuw, Karel F. A. Van Damme, Jozefien Declercq, Cedric Bosteels, Bastiaan Maes, Simon J. Tavernier, Laurent Detalle, Trevor Smart, Sophie Glatt, Nincy Debeuf, Julie Deckers, Sahine Lameire, Stefaan J. Vandecasteele, Nikolaas De Neve, Ingel K. Demedts, Elke Govaerts, Christiane Knoop, Karolien Vanhove, Michel Moutschen, Wim Terryn, Pieter Depuydt, Eva Van Braeckel, Filomeen Haerynck, Tine C. J. Hendrickx, Vanessa Parrein, Marianna Lalla, Claire Brittain, Bart N. Lambrecht

Get full text